Lucy Hale to star in Roku limited series Scarlett Holmes
Actress Lucy Hale will lead a new romantic mystery limited series called Scarlett Holmes on the Roku Channel.
Archives: Stories
Dirty Dancing Musical Opens Broadway Run At Lena Horne Theatre In 2027
Dirty Dancing: The Musical will open a limited engagement at the Lena Horne Theatre in New York from February 12, 2027 through September 5, 2027.
Steven Spielberg to oversee eighth Transformers film at Paramount
Steven Spielberg will oversee creative aspects and executive produce the eighth live-action Transformers movie for Paramount Pictures.
RedBird Capital Partners invests $4 billion in Paramount Warner Bros merger
RedBird Capital Partners provided $4 billion in new equity financing to fund the closing of Paramount's takeover of Warner Bros Discovery.
Emmys move to Amazon Prime Video in six-year global deal starting 2027
The Television Academy announced a six-year agreement with Amazon Prime Video to host the Primetime Emmys globally beginning in September 2027.
Jim Furyk says US team are underdogs in 2027 Ryder Cup
US captain Jim Furyk stated his team will be underdogs at the 2027 Ryder Cup at Adare Manor in Ireland next September.
Million non-smokers now vape daily or occasionally across Great Britain
Office for National Statistics data shows 1.1 million people in Great Britain used e-cigarettes despite never smoking regular cigarettes in 2025.
Orforglipron pill helps menopausal and non-menopausal women lose weight
Researchers presented new analysis showing orforglipron promotes weight loss in women of all ages at the European Association for the Study of Diabetes meeting in Milan.
Doctors warn surgery risks rise for patients using weight loss injections
Australian and New Zealand anaesthetists warn that patients using GLP-1 drugs or unapproved peptides face serious surgical risks if they do not disclose their medication use.
Adults switching from injectable GLP-1 drugs to Wegovy pills lost weight in study
A retrospective analysis presented at the 2026 European Association for the Study of Diabetes meeting in Milan found that adults with overweight or obesity who switched from injections to the oral semaglutide pill lost an average of 4.1 percent of their body weight over three months.